Cliniminds Delhi NCR Noida Certification Signal Detection and Risk Management: Fees 2026, Course Duration, Dates, Eligibility

Ans. Disproportionality analysis uses statistical measures such as Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) to identify drug-adverse event combinations reported more frequently than statistically expected in spontaneous reporting databases like FAERS and VigiBase. The programme provides hands-on exercises in applying these methods to real-world pharmacovigilance signal detection scenarios for FDA and EMA reporting.

Ans. The programme is designed for working pharmacovigilance professionals with at least foundational PV experience who want to specialise in signal detection and risk management functions. Drug safety associates, PV scientists, and medical safety reviewers seeking to advance into signal management or risk minimisation roles are the primary target audience for this focused module.

Ans. A Risk Management Plan (RMP) is an EMA-required document under GVP Module V that describes a medicine’s safety profile, risk minimisation activities, and pharmacovigilance plan. The programme covers RMP structure, safety concerns identification, additional risk minimisation measures (aRMMs), and REMS (Risk Evaluation and Mitigation Strategies) preparation for FDA submissions, with case study exercises on preparing RMP sections.

Ans. The EU Pharmacovigilance Risk Assessment Committee (PRAC) evaluates safety signals for human medicines through a structured process involving signal detection in EudraVigilance, benefit-risk assessment, and recommendations on marketing authorisation conditions. The programme covers the PRAC signal assessment workflow, signal validation criteria, and the regulatory implications of PRAC recommendations for marketing authorisation holders.

Ans. The 4-week certificate programme is delivered in part-time mode via the Cliniminds online platform, with sessions structured around current work commitments. Candidates receive access to study materials, disproportionality analysis exercises using signal detection datasets, and faculty consultation sessions. Contact Cliniminds at cliniminds.com for the current batch schedule and registration process.

Ans. Graduates receive the Cliniminds Certificate in Signal Detection and Risk Management along with an LSSSDC (Life Sciences Sector Skill Development Council) certification recognised under the National Skill Development Corporation framework. This credential is recognised by pharma companies and CROs in India as a validated signal detection and risk management competency qualification.